A cross-sectional study of the association between COVID-19 infection and psychological distress in Japanese workers

1. Introduction

COVID-19, which was identified in 2019 and spread worldwide, has caused enormous numbers of infections worldwide in repeated waves of transmission. In Japan, as of February 2023 a total of more than 33 million people have been infected (Ministry of health, Labor and Welfare of Japan, 2023). The global fatality rate reportedly decreased from 8.5% February 2020 to 0.27% August 2022, attributable to greater vaccine uptake, effectiveness of treatment, acquisition of immunity, and progressive weakening of the virus (Horita et al., 2023). The breakdown of acute severity of 457 patients in Japan discharged after treatment for COVID-19 was 84.4% mild, 12.7% moderate, and 2.9% severe. Symptoms in the acute phase included olfactory impairment (7.7%), fatigue (6.6%), dyspnea (3.9%), impaired taste (3.5%), and cough (2.4%). Fewer than 5% of patients reported still having symptoms after one year, but in some cases the latter can become chronic (Tsuzuki et al., 2022).

The persistence of symptoms in some patients is referred to as “post-COVID-19 conditions” or “long COVID”. The World Health Organization (WHO) defined post-COVID-19 conditions as symptoms lasting at least 2 months and not explained by other diseases. Symptoms that appear after the acute phase include memory impairment, poor concentration, and depression. These symptoms remained in 10% of patients after 6 month and in about 5% after 1 year (Miyazato et al., 2022). Recently, reports on long COVID have been increasing. An analysis of U.S. medical cost reimbursement data showed that 27,698 (32%) of 87,337 patients with COVID-19 had sequelae, with increasing the likelihood of long COVID including respiratory failure, hypertension, memory impairment, renal impairment, and psychiatric disorders (Ettman et al., 2022). In addition, a study of cognitive dysfunction in elderly COVID-19 patients reported an increased risk of developing cognitive dysfunction six months later compared to non-COVID-19 patients with other severe or mild illness (Liu et al., 2022).

Long COVID may lead to various psychiatric and neurological symptoms. Studies have reported increased number of patients presenting with depressive and anxiety symptoms after COVID-19 infection, with depressive symptoms particularly more likely to persist (Fancourt et al. 2022). In a report from Japan, fatigue (13%), poor concentration (8%), sleep disturbance (7%), and memory impairment (7%) were reported as residual symptoms 1 year after COVID-19 diagnosis (Nakagawara et al., 2021). In a large survey of U.S. veterans, one year after COVID-19 survivors were 46% more likely than controls to have been diagnosed with a psychiatric disorder: the latter included depression, suicidal ideation, anxiety, sleep disorders, and cognitive dysfunction (Xie et al., 2022). Analyses of data from 236,379 cases, mainly in the U.S., revealed that 34% of COVID-19 patients developed a psychiatric disorder within six months, and that after recovery, psychiatric disorders such as depression and anxiety were more common than influenza and other respiratory infections (Taquet et al., 2021).

Psychological manifestations of long COVID-19 have been related to not only biological mechanisms associated with the infection, but also to psychological and socioeconomic factors. In a review of the psychological effects of isolation at home or in quarantine facilities during the COVID-19 pandemic, most studies were shown to report psychological effects such as trauma, confusion, and anger (Brooks et al., 2020). It is widely known that deprivation of social interaction due to isolation has negative psychological effects (Valtorta et al., 2012). In Japan, early COVID-19 infection cases were subjected to 2-week quarantine reduced to 10 days from December 2020.

Although the number of cases of infection in Japan continues to rise, there are no reports on psychological problems after the experience of infection. We hypothesized that mental problems after infection experience would be related to experience of discrimination. Indeed, discrimination, inhibition, and social exclusion occur in the context of various infectious diseases, with COVID-19 infected individuals and their close contacts reportedly more vulnerable to unemployment and economic disadvantages (Wilson et al., 2020). Such negative consequences are thought to be linked to post-infection psychiatric symptoms. We therefore examined whether discriminatory experiences affect post-infection psychological problems among COVID-19-infected individuals.

2. Methods

3. Results

Table 1 shows the general characteristics of the 14,901 people who provided data for analysis. Of these, 166 (1.1%) had a history of infection. Age, marital status, occupation, education, and alcohol consumption items were similar between those with and without a history of infection. In contrast, univariate analysis showed that those with a history of infection were more likely to be male, had higher K6 scores, and more likely to feel they had suffered economically or had been treated unfairly.

Table 2 shows the Odds Ratio (OR) between infection experience and K6, as estimated by the logistic model. The age-sex adjusted OR for the association between infection experience and higher K6 was significant (OR=2.75, 95%CI 1.85-4.00). The association result was also significant in multivariate analysis model 2 (adjusted for baseline K6) with OR=2.15, 95%CI 1.42-3.26. In model 3 (adjusted for “feeling treated unfairly”), the association between infection experience and a high K6 score was significantly attenuated (OR=1.61, 95%CI 1.02-2.55).

4. Discussion

The follow-up survey revealed that 1.1% of the 14,901 people whose data were analyzed had a history of infection, and that experiencing COVID-19 infection was associated with psychological distress. Moreover, the psychological distress of infected individuals was at least partially explainable by their experience of unfair treatment. To our knowledge, this is the first large-scale study in Japan to investigate the history of COVID-19 infection and psychological distress.

In this study, individuals without psychological distress at baseline were at higher risk of developing psychological distress after experiencing COVID-19 infection. Mental health effects after infection are a typical symptom of long COVID (Fancourt et al., 2022). Neurological and psychiatric symptoms are associated with numerous types of viral infection, but long COVID differs from other viral infections in that symptoms may be unremarkable at the time of infection but develop after a mild or moderate bout (Choutka et al., 2022). Long COVID is thought to be caused not only by biological mechanisms associated with infection, but also by socio-psychological factors (Wadman et al., 2022; Brooks et al., 2020; Valtorta et al., 2012).

Concerning biological mechanisms, symptoms of long COVID, including reduced ability to speak, remember, or concentrate have been reported after infection. These cognitive sequelae are referred to as “brain fog,” and recently proposed to be related to brain inflammation in depression (Beurel et al., 2020; Steardo et al., 2020). Activation of antibodies and deposition of amyloid aggregates are among the possible underlying mechanisms (Apple et al., 2022; Fernandez et al., 2022; Charnley et al., 2022). It has also been noted that the symptoms of long COVID are similar to those experienced by patients undergoing cancer chemotherapy and those with myalgic encephalomyelitis, chronic fatigue syndrome, and mast cell activation syndrome. It has been suggested that mast cells stimulated by pathogenic viruses or stress stimuli may activate microglia and induce hypothalamic inflammation (Theoharis et al., 2021).

Concerning socio-psychological factors, in Japan, people with COVID-19 were originally required by law to be isolated for about 2 weeks in a hospital, convalescent hotel, or at home. Restrictions on home life and employment due to isolation are known to have psychological consequences (Valtorta et al., 2012). A study of Chinese youths reported increased suicidal ideation and self-harm after the strict COVID-19 social isolation policy was enforced (Zhang et al., 2020). Moreover, the recommendation of social distancing as a countermeasure against the spread of COVID-19 led to spread of other problems worldwide, such as loneliness and isolation. Whereas spending time with family members during a pandemic reduces loneliness (Fujii, et al.2022), social distancing among family members may exacerbate feeling of loneliness. In addition, the increasing number of infected persons in Japan resulted in, scattered cases of infection within families. Fear that family members may become infected is associated with psychological distress (Wang et al., 2021). During a pandemic the family serves as a buffer, while the endangerment of family well-being can alter resilience (Prime et al., 2020).

There may be socioeconomic disadvantages for infected individuals, as those who have been infected or had close contact with the disease are reported to be at higher risk of unemployment (Nagata et al., 2021). Reduced income during the pandemic, and insecurity surrounding employment and finances are reported to increase the risk of depression, anxiety, and insomnia, requiring early psychological support and some form of intervention (Li et al., 2020; Wilson et al., 2020). Furthermore, during the COVID-19 pandemic, delayed return to work was found to negatively impact mental health (Shi et al., 2020).

It is against this general background that experiences of discrimination and stigma appear relevant. Under a pandemic, stigma is not merely possible, but a common phenomenon (Xiang et al., 2020), and stigma associated with COVID-19 has already been identified as an important stressor (Hamouche et al., 2020; Giorgi et al., 2020). It is directed at infected persons and those who come in contact with them (Bai et al., 2004; Brooks et al., 2020). Essential workers may be required to continue working even during a pandemic despite strains on mental health due to constantly being on guard against unexpected contact and resulting stigma and discrimination (Sasaki et al., 2021). For example, in Japan, a social problem arose early in the COVID-19 epidemic when children of nurses and other health care workers were denied access to daycare centers. Complaints about discrimination related to COVID-19 are common in the workplace (Choi et al., 2021; Kantamneni et al., 2020). Because they may increase feeling of shame and guilt in the target individual, discrimination and stigma can lead to reduced feelings of self-worth (Corrigan et al., 2002). These findings are supported by the results of the present study: the association between experience of infection and K6 score was greatly attenuated when adjusted for discriminatory experiences.

The present study suggests that secondary feelings of being treated unfairly, or so-called stigma issues, have a significant role in the emergence of psychological distress. Reports on COVID-19 infection and risk of psychiatric disorders continue to grow in number, and in parallel with the search for biological mechanisms, clarification of psychosocial aspects is required. COVID-19-infected individuals may experience a double burden of clinical distress as well as stigmatizing social disadvantage; they experience decreased self-worth and disconnection from society following COVID-19 infection, and secondary environmental changes that follow infection. Even after symptoms are in remission, medium-to long-term care, including social support, is needed. To address stigma and preserve the patient’s self-respect, the patient should not be socially isolated, should enjoy positive relationships with family and friends, and have appropriate interactions with others (Lubkin et al., 2007). In addition, WHO has expressed concern about infodemics with respect to COVID-19 (Novel Coronavirus.situation report, 2020). It is important to provide correct information in real time to prevent stigma exacerbation through misinformation (Hamouche et al., 2022). Measures to adequately address stigmatizations may help to counter post-infection psychological distress.

Credit statement

YF: The chairperson of the study group, Conceptualization, Methodology, Formal analysis, Editing; HT: Original draft, Writing and Editing.

Funding statement

This study was supported by a research fund from the University of Occupational and Environmental Health, Japan; General Incorporated Foundation (Anshin Zaidan); The Development of Educational Materials on Mental Health Measures for Managers at Small-sized Enterprises; Health, Labour and Welfare Sciences Research Grants; Comprehensive Research for Women’s Healthcare (H30-josei-ippan-002); Research for the Establishment of an Occupational Health System in Times of Disaster (H30-roudou-ippan-007), and scholarship donations from Chugai Pharmaceutical Co., Ltd.